KR20130141420A - Composition for treatment of ischemic heart disease, facilitation of blood circulation and angiogenesis - Google Patents

Abstract

The present invention relates to a composition for promoting blood circulation including the ginseng fruit extract as an active ingredient, a composition for blood vessel anti-aging, a blood vessel inflammation therapeutic composition, an angiogenesis promoting composition, a composition for treating ischemic heart diseases,a composition for relieving and treating partial blood flow shortage, in particular, and to a composition which includes ginseng fruit extract as an active ingredient to promote the generation of NO, the survival of blood vessel endothelial cell, and to accelerate the vascularization of blood vessel through the portability increment of the blood vessel endothelial cell and blood vessel tube production. [Reference numerals] (AA) Untreated group;(BB) Comparative example 1 100ug/ml;(CC) Example 1 100ug/ml;(DD) Example 2 100ug/ml;(EE) Untreated group;(FF) Untreated group contrast intensity (compared to untreated group %);(GG) Comparative example 1;(HH) Example 1;(II) Example 2

Description

Composition for the treatment of blood circulation, angiogenesis, and ischemic heart disease containing ginseng fruit extract {Composition for treatment of ischemic heart disease, facilitation of blood circulation and angiogenesis}

The present invention relates to a composition for promoting blood circulation, a composition for preventing vascular aging, a composition for treating vascular inflammation, a composition for promoting angiogenesis, a composition for treating ischemic heart disease, and a composition for improving local blood deficiency and treating, containing ginseng fruit extract as an active ingredient. More specifically, the present invention contains ginseng fruit extract as an active ingredient to promote nitric oxide (NO) production in vascular endothelial cells, enhance the survival of vascular endothelial cells, increase the mobility of vascular endothelial cells and produce vascular tubes. The present invention relates to a composition for promoting angiogenesis.

Ginseng (Panax ginseng CA Meyer) is a plant belonging to the genus Ogapiaceae ginseng, which has been used in Korea, China and Japan for more than 2,000 years, and has been used to prevent disease and prolong life. Efficacy and effects on the central nervous system, anticarcinogenic effect, anticancer activity, immune function control effect, antidiabetic effect, hepatic antifungal effect, cardiovascular disorders improvement, anti-arteriosclerosis, blood pressure control action, menopausal disorder improvement, osteoporosis Effects, antistress and anti-fatigue, antioxidant activity and anti-aging effect (Latest ginseng 'components and efficacy', Korea Ginseng and Tobacco Research Institute, 56-112, 1996).

Ginsenoside, a representative physiologically active ingredient of ginseng, is distributed evenly on the ground and underground parts of ginseng. Especially, ginsenoside content and composition are different depending on the parts such as ginseng root (root), ginseng leaf and ginseng fruit. (Attele AS et al, Biochem Pharmacol, 58; 1685-1693, 1999). Among them, ginseng fruit showed better results than ginseng root in antidiabetic efficacy based on ginseng root (root) and other ginsenoside components and ingredients (Dey L. et al., Phytomedicine, 10; 600). -605, 2003).

In addition, ginseng fruit is considered more precious than ginseng since ancient times, and has been selected and harvested for the purpose of obtaining seeds. Ginseng fruit is harvested only once in 4 years of ginseng cultivation period. It is difficult to produce good seedlings because seed is too small when harvested in 3 years old. Seeds are faithful and good when grown in 5 years old or older. In addition to inhibiting development, the tissue is not dense, so red ginseng quality may be greatly reduced when manufacturing red ginseng. In addition, the yield and red ginseng quality are greatly reduced when the number of seedings is collected more than two times during the cultivation period.

On the other hand, in the blood circulation, especially peripheral blood circulation may be said to be necessary for the expansion of the capillaries. In other words, increased blood flow in blood vessels is a mechanism that requires expansion of blood vessels, and nitric oxide (NOtric) by the action of endothelial nitric oxide synthase (eNOS) is involved to expand blood vessels. Thus, in the case of hypertension, it is true that NO production is reduced (Forete, P. et al., Basal nitric acid synthesis in essential hypertension. Lancet. 1997; 349: 837-842). In addition, factors such as aging, smoking, hyperlipidemia and diabetes in humans contribute to the reduction of NO production in blood vessels (Crossman, DC.More problems with wndothelium. Q J Med. 1997; 90: 157-160).

Angiogenesis is a series of processes in which new blood vessels are made from existing blood vessels, invasion through the extracellular matrix (ECM), the intracellular barrier, and the migration of endothelial cells that make up blood vessels. , Proliferation, and blood vessel differentiation (tube production) (Folkman, J. et al., Angiogenesis. The Journal of Biological Chemistry, 1992, 267 (16), 10931-10934).

Angiogenesis in a physiological state may occur temporarily due to fetal development, menstruation and local oxygen deficiency in women, and in the ischemic disease or fracture, the supply of blood flow is not smooth and therapeutic angiogenesis is utilized. In addition, mortality from atherosclerosis due to atherosclerosis occupies the world's leading level and is rapidly increasing in Korea (Jin Jin-ok et al., Angiogenesis Therapeutics. Journal of the Korean Society for Vascular Surgery. 2000. 16 (2), 265-269) ).

Attele AS et al, Biochem Pharmacol, 58; 1685-1693, 1999

An object of the present invention is to use a ginseng fruit extract to promote blood circulation, enhance the survival of vascular endothelial cells, promote the mobility of vascular endothelial cells, promote the formation of vascular endothelial cells to promote angiogenesis composition To provide.

Therefore, in order to solve the above problems, the present inventors studied ginseng promotion, vascular aging, and angiogenic effects using ginseng fruit, which is the ground part of ginseng, and the ginseng fruit extract was prepared by different ingredients and composition from general ginseng root and red ginseng root. Discovering efficacy in blood vessels, the present invention has been completed.

Utilizing the composition containing the ginseng fruit extract of the present invention, it can be used for the treatment of ischemic heart disease such as arteriosclerosis, angina pectoris, and myocardial infarction by promoting blood circulation by dilating blood vessels, inhibiting vascular aging, and promoting angiogenesis. It can be used for the treatment and improvement of local hepatic insufficiency due to arthritis or fracture.

Figure 1a is a picture taken with a confocal laser microscope of vascular endothelial cells, 1b is a graph showing the intensity of fluorescence compared to the untreated group by analyzing the brightness of the fluorescence.
Figure 2a is a picture of the proliferation of surviving vascular endothelial cells, Figure 2b is to compare and measure the absorbance of the stained vascular endothelial cells.
Figure 3a is a photograph of the mobility of the stained vascular endothelial cells, 3b is a graph showing the number of cells compared to the mobility of the untreated group.
Figure 4a is a photograph of fixed staining vascular endothelial cells, 4b is a graph showing the length of the tube formed compared to the tube formation compared to the untreated group.
Figure 5a is a photograph of the observation of the expansion of new blood vessels in the form of capillary vessels around the aortic vessel using an optical microscope, 5b is to evaluate the effect of promoting vessel sprouting by the length and number of newly formed germination, blood vessels It is a graph showing the result of marking the score.
FIG. 6A is a photograph taken in real time by an intravital fluorescence microscopy of the angiogenesis in the mouse, and 6b is the smallest change from 0 to 5 with the smallest change analyzed using a computer program. It is a graph showing the score up to.
Figure 7 is a graph showing the results of measuring the amount of NO produced in order to compare the effect of inhibiting NO induced by LPS.
8 is a graph showing the results of confirming the amount of NO production, the production of inflammatory factors PGE2, TNF-α, IL1-β from mouse blood.

In order to achieve the above object, the present invention, the composition for promoting blood circulation, the composition for preventing vascular aging, the composition for treating vascular inflammation, the composition for promoting angiogenesis, the composition for treating ischemic heart disease and the local blood flow It provides a composition for improving deficiency and treatment.

In the composition for treating ischemic heart disease of the present invention, the ischemic heart disease is characterized in that arteriosclerosis, angina pectoris or myocardial infarction.

In the composition of the present invention, the ginseng fruit extract is characterized in that it is prepared by adding ethanol to the dried ginseng fruit, reflux extraction, filtration, concentrated, remove the fat-soluble components, and then extracted and concentrated by adding butanol.

Hereinafter, the present invention will be described in more detail.

The present invention contains ginseng fruit extract as an active ingredient, promotes NO production in vascular endothelial cells to facilitate blood circulation, enhance the survival of vascular endothelial cells, and promote the differentiation and migration of vascular endothelial cells, Provided are compositions that promote neovascular production.

The ginseng fruit extract is mixed in a ratio of 0.01% to 100% according to the form of the composition, the ginseng fruit extract-containing composition of the present invention can be used as an additive of food, medicine.

When applied to medicines, ginseng fruit extract according to the present invention can be formulated as an oral or parenteral dosage form in the form of solid, semi-solid or liquid by adding a commercially available inorganic or organic carrier as an active ingredient.

Examples of preparations for oral administration include tablets, pills, granules, soft and hard capsules, powders, fine granules, powders, emulsions, syrups and pellets. have. Preparations for parenteral administration include injections, drops, ointments, lotions, sprays, suspensions, emulsions, suppositories, and the like. In order to formulate the active ingredient of the present invention, it can be easily formulated according to the conventional method. Surfactants, excipients, coloring agents, spices, preservatives, stabilizers, buffering agents, suspending agents and other adjuvants can be suitably used.

The pharmaceutical composition according to the present invention may be administered orally, parenterally, rectally, topically, transdermally, intravenously, intramuscularly, intraperitoneally, subcutaneously and the like.

In addition, the dosage of the active ingredient will depend on the age, sex, body weight of the subject to be treated, the particular disease or condition to be treated, the severity of the disease or condition, the route of administration and the judgment of the prescriber. Dosage determination based on these factors is within the level of those skilled in the art, and generally the dosage ranges from 0.001 mg / kg / day to approximately 2000 mg / kg / day. A more preferred dosage is 0.5 mg / kg / day to 2.5 mg / kg / day.

When applied to functional foods, ginseng fruit extract according to the present invention as an active ingredient, by appropriately selecting the ingredients commonly used in the art, tablets, capsules, soft capsules, pills, granules, drinks (drinks), It can be formulated into a diet bar, chocolate, caramel formulation or confectionary formulation. In addition, functional ingredients suitable for health foods may additionally be appropriately used.

Hereinafter, the present invention will be described in detail with reference to Examples, but the technical scope of the present invention is not limited to these Examples.

Example 1 Preparation of Ginseng Fruit Extract

1) Ginseng fruit pretreatment: Raw ginseng fruit was harvested to isolate and remove seeds, and then the ginseng fruit dried raw material was prepared by sunlight drying or hot air drying.

2) Preparation of ginseng fruit extract: 3 g of ethanol dried fruit was added to reflux to extract reflux, filtered and concentrated under reduced pressure at 40 ~ 45 ℃ to obtain 300 g of ginseng fruit extract.

Example 2 Preparation of Ginseng Fruit Extract

1) Dissolve 100 g of ginseng fruit extract obtained in Example 1 in 1 L of water, add 500 ml of diethyl ether, and remove the fat-soluble component using a separatory funnel. Then, 500 ml of water-saturated butanol was added to the remaining water layer to obtain butanol layer three times, and then concentrated under reduced pressure to obtain 60 g of ginseng fruit extract (irradiated ponin).

Comparative Example 1 Preparation of Ginseng Root Extract

Except for using ginseng root (root) instead of ginseng fruit in Example 1 was prepared in the same manner as in Example 1.

Test Example 1 Comparison of Ginseng Fruit Extract and Ginseng Root Composition

1.Ginsenoside (Ginseng Saponin) Analysis

In Example 1 and Comparative Example 1, respectively, ginseng fruit and ginseng root extract were prepared, and these extracts were treated with ether to remove fat-soluble components, followed by extraction of crude saponin with butanol (BuOH) and concentration. It was. Component analysis of ginsenoside (ginseng saponin) in irradiated irradiated with HPLC was performed, and the results are shown in Table 1 below.

Example 1 Comparative Example 1 Irradiation Ponine Content
(Ginseng saponin total amount)
(Dry weight) 33.42% 16.70% PD / PT ratio 0.73 3.23

The ginseng fruit extract prepared in Example 1 has about twice as much irradiation ponin content as the ginseng root extract prepared in Comparative Example 1. The composition of ginsenosides in the ratio of PD (Protopanaxadiol) (Ginsenosides Rb1, Rb2, Rc and Rd) and PT (Protopanaxatriol) (Ginsenosides Re, Rg1 and Rg2) was 0.73 and 3.23, respectively. The ginseng fruit and ginseng root showed distinct differences and characteristics in.

2. Analysis of Mineral Components of Ginseng Fruit Extract

The ginseng fruit extract prepared in Example 1 was 'fruit' different from ginseng root, and it was considered that it would contain vitamin and mineral components which are hardly contained in ginseng root, and the component analysis was performed. Shown in

ingredient content ingredient content Potassium (mg / 100g) 5865.57 Magnesium (mg / 100g) 354.38 Calcium (mg / 100g) 819.26 Zinc (mg / 100g) 178.49 Iron (mg / 100g) 59.31 Vitamin A
(μg / 100g, RE) 213.11 Phosphorus (mg / 100g) 187.17 Vitamin B1 (mg / 100g) 12.29 Vitamin B2 (mg / 100g) 8.45 Vitamin B6 (mg / 100g) 10.50 Vitamin C (mg / 100g) 4.91 Vitamin E
(mg / 100g, α-TE) 23.61 Vitamin K (μg / 100 g) 232.12 Niacin
(mg / 100g, NE) 5.76 Pantothenic Acid (mg / 100g) 5.87 Folic acid (μg / 100g) 349.97

As mentioned above, the ginseng fruit used in the present invention contains more ginseng saponin than the ginseng root, and at the same time, the nature of the saponin composition is very different, and unlike ginseng root, it was confirmed that the fruit is rich in 16 kinds of vitamins and minerals. . Based on this, the following experiments on the efficacy in blood vessels were conducted.

Experimental Example 2 NO Production of Ginseng Fruit Extract in Human UVB (Human umbilical vein endothelial cell)

Endothelial nitric oxide synthase (eNOS) is present in human vascular endothelial cells, and its activity is increased to produce NO (nitric oxide) to expand blood vessels and promote blood circulation. After culturing human vascular endothelial cells, ginseng fruit extracts (Examples 1 and 2) and general red ginseng root extracts (Comparative Example 1) were compared to the amount of NO produced.

Endothelial cells attach to a gelatin coated 24-well plate at a density of 2.5 x 10 ⁴ cells / well. Cells are incubated for 12 hours in growth medium. Vascular endothelial cells were treated with ginseng fruit extract and general red ginseng root extract (Examples 1 and 2, Comparative Example 1) and untreated group for 12 hours. It is then treated for 30 minutes with 10 μmol / L DAF-FM diacetate (Molecular Probe, OR) in M199 medium without FBS at 37 ° C. Thereafter, the vascular endothelial cells were washed three times with M199 medium without FBS, placed in a parallel plate flow chamber, and stimulated with light separated from a mercury lamp. The excitation wavelength is 488 nm and when NO is bound to DAF, it fluoresces at 515 nm. Figure 1a is a photograph taken with a confocal laser microscope (Atoto Bioscience, USA), 1b is the brightness of the fluorescence analyzed by Image-Pro Plus v4.5 software (Media Cybernetics, San Diego, CA, USA) It is a graph showing the intensity of fluorescence compared to the untreated group.

As can be seen in Figure 1, the ginseng fruit extract of Example 1, Example 2 according to the present invention showed a degree of NO production of 1300% ~ 2000% compared to the untreated group at a concentration of 100 ug / ml, of Comparative Example 1 The general red ginseng root extract showed 100-200% NO production at the same concentration of 100 ug / ml. In particular, the extract of Example 2 produced more NO. Therefore, the ginseng fruit extract is significantly superior to the NO production in vascular endothelial cells compared to the general red ginseng root extract. The excellent NO (nitric oxide) production ability of the ginseng fruit extract of Example 1 and Example 2, in turn, has the effect of dilatating blood vessels and promoting blood circulation.

[Test Example 3] vascular endothelial cell survival rate regulation effect (cell viability)

Inhibiting aging of blood vessels and the most basic step in the formation of blood vessels can be said to promote the activity of vascular endothelial cells. The survival rate of vascular endothelial cells in the ginseng fruit extract (Examples 1 and 2) treated group was compared with the positive control group (VEGF; Vescular endothelial growth factor).

The survival rate of vascular endothelial cells was measured using a crystal violet dye. First, vascular endothelial cells were attached to 24 wells with a cell number of 5 × 10 ⁴ , and then cultured in growth medium for 12 hours. Next, the cells were treated with M199 culture medium containing 1% serum for 6 hours to induce cell division in the same manner. Examples 1 and 2 were treated with 25, 50, and 100 μg / mL, respectively, and the positive control group was treated. After 18-24 hours, the culture medium was removed, and 300 µl of crystal violet dye was added to stain live vascular endothelial cells, and left at room temperature for about 30 minutes. After washing 2-3 times with physiological activity buffer (PBS), the cells were pulverized with 1% SDS solution and measured at an absorbance value of 550 nm to compare the positive control group with the groups treated with Examples 1 and 2, thereby increasing the survival rate of the cells. It was confirmed.

Figure 2a is a picture of the surviving vascular endothelial cells, Figure 2b is to compare and measure the absorbance of the stained vascular endothelial cells. According to the results of the photograph of FIG. 2A and the absorbance value of FIG. 2B, the ginseng fruit extract (Examples 1 and 2) treatment group had an effect of enhancing the survival rate of vascular endothelial cells and promoting the proliferation of living cells as compared to the non-treated group. In particular, in the case of Example 2, it was shown to enhance the survival and promote proliferation of vascular endothelial cells than the positive control group VEGF. Therefore, it can be seen that ginseng fruit extract suppresses aging of blood vessels and promotes angiogenesis by enhancing the survival rate and promoting proliferation of vascular endothelial cells.

[Test Example 4] HUVECs migration

Cell mobility, one of the common methods of measuring angiogenesis, was measured and analyzed. Cell mobility analysis was performed using Boyden's chamber (Transwell). In a 24-well plate, 600 μl of serum-free M199 medium was added, and the culture solution was treated with ginseng fruit extract (Examples 1 and 2, respectively, 25, 50, and 100 μg / mL) and the positive control group, and then the lower surface of the transwell. Gelatin (1 mg / ml) was smeared and 2 × 10 ⁴ cells were attached to the upper surface. After about 4 hours, the cells on the upper side were removed with a cotton swab and the cells moved to the lower side were stained with hematoxylin and eosin to leak all the stained cells. . Figure 3a is a photograph showing the mobility of the stained vascular endothelial cells, 3b is a graph showing the number of cells compared to the untreated group mobility.

As shown in Figure 3, Examples 1 and 2 showed the effect of promoting the mobility of vascular endothelial cells, in particular, the effect of Example 2 showed better results than the positive control group VEGF. Therefore, ginseng fruit extract can be said to promote the mobility of vascular cells, the main mechanism of angiogenesis.

Test Example 5 Tube-formation promoting effect of vascular endothelial cells

As a measure of angiogenesis control, the extent to which cells induce tube formation was examined. In general, the tube forming ability of the cells using a matrigel (matrigel). Smear 250 ul of Matrigel in a 24-well plate and attach 2.5x10 ⁴ cells onto Matrigel. Observe the tube formation of the untreated, positive control (VEGF), and ginseng fruit extract treatment groups (Examples 1 and 2) at regular intervals, and fix the cells at the appropriate time to determine the extent of tube formation. Analyzed using the program. Figure 4a is a photograph of the fixed stained cells, 4b is a graph showing the length of the tube formed versus tube formation compared to the untreated group.

As shown in Figure 4, Examples 1 and 2 showed a result of promoting the tube formation of the cell, the main mechanism of angiogenesis, especially in Example 2 showed a better effect than the positive control group.

[Test 6] Promoting Vessel Sprouting

As a method of measuring angiogenesis control, it was confirmed that germination from the blood vessels to the surroundings. SD rats were divided into untreated group, VEGF (vescular endothelial growth factor) treated group, and Example 1 and Example 2 ginseng fruit extract treated group. Incision of the chest of the rat to obtain an aortic blood vessel (Arotic ring) and stored in serum-free DMEM medium, and treated with VEGF and ginseng fruit extract (Examples 1 and 2) in the medium for each aortic vessel, respectively at about 37 ℃ Cultured for 7 days, the blood vessels germinated to the surroundings. Figure 5a is a photograph of the observation of the expansion of new blood vessels in the form of capillary vessels around the aortic vessel using an optical microscope, 5b is to evaluate the effect of promoting vessel sprouting by the length and number of newly formed germination, blood vessels The score is then marked.

As shown in Figure 5 ginseng fruit extract (Examples 1 and 2) showed the effect of promoting the germination of blood vessels, in particular in Example 2 showed an excellent effect than the positive control group. This can be said to support the efficacy on vascular nova.

Test Example 7 Angiogenesis-promoting Effect

Anesthetize male BALB / c mice about 6-8 weeks old using a mixture of 1.5% isoflurane and O ₂ / N ₂ O. A mouse window (19 mm in diameter, 14 mm in inner diameter, 0.7 mm thick) is attached to the mouse's abdomen. As a control, VEGF 20 ng, ginseng fruit extract (Examples 1 and 2) were mixed with Matrigel, respectively, inserted into the inner tissue of the window, covered with a cover slip, and fixed with a snap ring. Intravital fluorescence microscopy is used to monitor angiogenesis in real time. After 4 days, dextran (MW 250,000 Sigma Chemical, St. Louis, Missouri) labeled with fluorescein isothiocyanate (FITC) was tested at 25 mg / ml to determine the degree of angiogenesis. Inject 50 μl into the tail vein. FIG. 6A is an Electron-Multiplying CCD camera (Photon) in blue light (440-475 nm, excitation wavelength 530-550 nm, emission wavelength) with Zeiss Axiovert 200M microscopy (Oberkocchen, Germany), an intravital fluorescence microscopy. Max 512; pictures taken in real time using Princeton Instruments, Trenton, NJ), and 6b was analyzed using MetaMorph (Universal Imaging Corp., Downingtown, PA). The maximum score is 5.

As shown in Figure 6, ginseng fruit extract (Examples 1 and 2) showed the effect of generating new blood vessels in the animal, especially in Example 2 showed better efficacy in vascular nova than the positive control group. As a result, ginseng fruit extract promotes angiogenesis and is effective in ischemic cardiovascular disease, improved local blood flow, and rapid healing of chronic vascular inflammation.

Test Example 8 Effect of Ginseng Fruit Extract on Vascular Inflammation

1. Inhibition of LPS-induced NO (nitric oxide) on macrophage (in vitro)

In order to investigate the anti-inflammatory effects of ginseng fruit extract, an experiment was conducted to inhibit NO (nitric oxide) induced by LPS on macrophages.

Macrophages (Raw 264.7 cells) were incubated under 5% CO ₂ in medium with 10% serum. After growing at a concentration of 2 × 10 ⁵ in a 96-well plate incubator, and stimulated with LPS (1 ug / ml), the ginseng fruit extract of Example 1, Example 2, and the red ginseng root extract of Comparative Example 1 were treated. After storage for 1 hour at 37 ℃ to measure the degree of NO production was compared the effect of inhibiting NO induced by LPS. The measurement of NO production was carried out using Griess reaction method (Minghetti, L. et al., 1991, Glia 19. 152-160), the results are shown in FIG.

As shown in Figure 7, ginseng fruit extract according to the present invention (Examples 1 and 2) effectively inhibited NO production as an inflammation-inducing factor (Cytokine), the effect is much better than red ginseng root extract (Comparative Example 1) It was. In particular, Example 1 showed a better effect. Therefore, the ginseng fruit extract of Examples 1 and 2 according to the present invention can be said to be effective in ischemic diseases such as angina due to vascular inflammation and vascular inflammation through inflammatory response control.

2. Experiments on Vascular Inflammatory Control of Ginseng Berry Extract (in vivo)

Based on the results at the cellular level, we examined the efficacy of ginseng fruit extract on the vascular inflammation regulation in animal models. The mice were classified into five groups per experimental group, and were composed of the untreated group, the LPS-induced group, and the ginseng fruit extract treatment group of Examples 1 and 2.

For ginseng fruit extracts of Examples 1 and 2, 100 mg (1.5 mg / 15 g mouse) of 1 g of body weight of the mouse was diluted in 1 mL of saline solution (0.9% NaCl) from day 1 to day 3 Injection was intraperitoneally. Inflammatory factors were induced by intraperitoneal injection of a dilution in 1 mL of the serum solution at 4 mg / kg of mouse body weight for LPS 2 h after the third day of injection. After about 12 hours, the abdominal surgery was performed to cut the artery of the heart, and blood was collected and stored at -40 ° C. The blood was again left at room temperature for 30 minutes and then centrifuged at 3,000 rpm for 10 minutes, and the supernatant was stored at -20 ° C. NO production was measured from blood, and inflammatory factors PGE2, TNF-α, and IL1-β were electrophoresed and confirmed by Western blot. The results are shown in FIG.

 As shown in Figure 8 ginseng fruit extract (Example 1, Example 2) showed the effect of inhibiting the production of inflammatory factors induced by LPS, in particular Example 1 showed a better effect. This supports that ginseng fruit extract has the effect of inhibiting vascular inflammation and regulating vascular inflammation in ischemic disease.

Examples of the formulation of the composition are described below, but are not intended to limit the invention but merely to be described in detail.

Formulation Example 1 Injection

50 mg of ginseng fruit extract of Example 1, an appropriate amount of sterile distilled water for injection, and an appropriate amount of pH adjuster were mixed, and prepared according to the conventional method of preparing an injectable agent in the amount of the above-mentioned ingredient per ampoule (2 ml).

Formulation Example 2 Liquid

100 mg of ginseng fruit extract of Example 2, 10 g of isomerized sugar, 5 g of mannitol, and purified water amount were mixed, and each component was added to and dissolved in purified water according to a conventional method for preparing a liquid solution, and then a suitable amount of lemon flavor was added thereto. After mixing the ingredients, purified water was added and the whole was adjusted to 100 ml by adding purified water, and then filled into a brown bottle to sterilize to prepare a liquid.

Formulation Example 3 Soft Capsule

Ginseng fruit extract of Example 1 50mg, L-carnitine 80 ~ 140mg, soybean oil 180mg, palm oil 2mg, vegetable hardened oil 8mg, beeswax 4mg and lecithin 6mg, and filled with 400mg per capsule according to a conventional method to soft capsule Prepared.

Formulation Example 4 Tablet

50 mg of ginseng fruit extract of Example 2, 200 mg of galactooligosaccharide, 60 mg of lactose and 140 mg of maltose were mixed and granulated using a fluidized bed dryer, and then, 6 mg of sugar ester was added and tableted with a tablet press to prepare a tablet.

Formulation Example 5 Granules

50 mg of ginseng fruit extract of Example 2, 250 mg of anhydrous glucose and 550 mg of starch were mixed, molded into granules using a fluidized bed granulator, and then filled into fabrics.

Formulation Example 6 Drink Preparation

50 mg of ginseng fruit extract of Example 1, 10 g of glucose, 0.6 g of citric acid, and 25 g of liquid oligosaccharides were mixed, and 300 ml of purified water was added thereto, and 200 ml were filled in each bottle. After filling the bottle sterilized for 4 to 5 seconds at 130 ℃ to prepare a beverage.

Claims (5)

A composition for preventing vascular aging containing ginseng fruit extract as an active ingredient. The method of claim 1,
Wherein said composition prevents or treats vascular inflammation. The method of claim 1,
The composition is a composition for preventing or treating ischemic heart disease. 4. The method according to any one of claims 1 to 3,
The ginseng fruit extract is a reflux extraction, filtration, concentrated by adding ethanol to the dried ginseng fruit dried, after removing the fat-soluble components, butanol extracted, concentrated composition. The method of claim 3,
The ischemic heart disease is atherosclerosis, angina or myocardial infarction.

Images